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Abstract 
 
Mutations in Norrin, the ligand of a receptor complex consisting of FZD4, LRP5 and TSPAN12, cause 
severe developmental blood vessel defects in the retina and progressive loss of the vascular system in 
the inner ear, which lead to congenital blindness and progressive hearing loss, respectively. We now 
examined molecular pathways involved in developmental retinal angiogenesis in a mouse model for 
Norrie disease. Comparison of morphometric parameters of the superficial retinal vascular plexus 
(SRVP), including the number of filopodia, vascular density and number of branch points together with 
inhibition of Notch signaling by using DAPT, suggest no direct link between Norrin and Notch signaling 
during formation of the SRVP. We noticed extensive vessel crossing within the SRVP, which might be a 
loss of Wnt- and MAP kinase-characteristic feature. In addition, endomucin was identified as a marker 
for central filopodia, which were aligned in a thorn-like fashion at P9 in Norrin knockout (Ndpy/-) mice. 
We also observed elevated mural cell (MC) coverage in the SRVP of Ndpy/- mice and explain it by an 
altered expression of PDGFβ and its receptor (PDGFRβ). In vivo cell proliferation assays revealed a 
reduced proliferation rate of isolectinB4 positive cells in the SRVP from Ndpy/- mice at postnatal day 6 
and a decreased mitogenic activity of mutant compared to the wildtype Norrin. Our results suggest that 
the delayed outgrowth of the SRVP and decreased angiogenic sprouting in Ndpy/- mice are direct effects 
of the reduced proliferation of endothelial cells from the SRVP. 
Introduction 
Mutations in the human NDP (Norrie disease pseudoglioma) gene, encoding Norrin, cause congenital 
blindness, progressive deafness and mental retardation, a triad of symptoms  characteristic for Norrie 
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Disease (ND) (1-5). Alternatively, mutations in NDP can exclusively lead to ocular symptoms in X-linked 
exudative vireoretinopathy (EVR)(6), Coats’ disease and retinopathy of prematurity (7,8). EVR is also 
caused by mutations in Frizzled-4 (FZD4, FZD4), low-density lipoprotein receptor-related protein 5 (LRP5, 
LRP5) or Tetraspanin-12 (TSPAN12, TSPAN12) (9-11). Recessive mutations in Lrp5 may also cause 
osteoporosis pseudoglioma syndrome (OPPG), which manifests with low bone mass in addition to the 
ocular phenotype in patients (OMIM: #259770). It has been shown in vitro that Norrin is a ligand for the 
canonical Wnt signaling receptor complex consisting of FZD4, LRP5 and TSPAN12 (12,13). Furthermore, 
the outgrowth of the superficial retinal vascular plexus (SRVP) from Ndpy/-, Fzd4-/-, Lrp5-/- and Tspan12-/- 
is delayed and incomplete and all of these knockout mice lack the deep and intermediate retinal 
vascular plexuses (12-16). We generated and examined a Norrin knockout mouse model (Ndpy/-) that 
resembles the human Norrie disease phenotype with respect to blindness and hearing loss (4,14,17). 
Hyaloid vessels do not completely regress in Ndpy/-, Fzd4-/-, Lrp5-/- and Tspan12-/- knockout mice (12-
14,16). Retinal vascular hemorrhage and exudation from retinal blood vessels in Ndp knockout mice 
(Ndpy/-) are characteristic features. We previously demonstrated that expression of the plasmalemma 
vesicle-associated protein (PLVAP), which mediates vascular fenestration and promotes vascular 
leakiness, is highly upregulated in Ndpy/- retinas (18). Upregulation of PLVAP/MECA32 in retinal 
endothelial cells has also been shown for Lrp5-/- and Tspan12-/- mice (13). Furthermore, it was shown 
that upregulation of PLVAP indicates the loss of canonical Wnt signaling (19). The delayed outgrowth of 
the SRVP and the absence of deep sprouting could be caused either by defects in sprouting angiogenesis 
or by reduced proliferation of the SRVP. Sprouting angiogenesis is mediated by endothelial tip cells that 
guide the growing SRVP from the optic nerve head towards the retinal periphery along a VEGF gradient 
(20). Tip cell adjacent stalk cells divide ensuring proliferation and growth. Thus, an imbalance of tip and 
stalk cells could lead to both observed effects. The proper differentiation of tip and stalk cells is 
mediated by a balanced expression and interaction of Notch1 with its ligands Dll4 and Jagged1 (21-23). 
Dll4 is expressed in tip cells and induces Notch signaling in adjacent stalk cells. In contrast, Jagged1 is 
expressed in stalk cells impeding Notch signaling in adjacent tip cells. Disruption of Notch signaling have 
been shown to alter morphometric parameters such as the number of peripheral tip cell filopodia, 
vascular density and the number of vascular branch points. The outgrowth of the SRVP along the VEGF 
gradient involves MAPK signaling. VEGF, provided by astrocytes or retinal ganglion cells, binds a receptor 
complex consisting of VEGF receptor 2 (VEGFR2) and neuropilin 1 (Nrp1) activating downstream MAPK 
signaling. Loss of the cytoplasmatic Nrp1 domain (Nrp1cytoΔ/Δ) or nestin specific knockout of VEGF 
(VEGFNES-CRE) in mice causes artery/vein crossing in the SRVP of these mice. VEGFNES-CRE mice additionally 
show aberrant deep sprouting (24,25). 
Here, we focused on defects during development of the SRVP in Ndpy/- mice. We quantified several 
vascular and angiogenic parameters and observed extensive vessel crossing within the SRVP which 
might be a Wnt-characteristic feature. We found reduced cell proliferation in the SRVP at the vascular 
front at P6 in Ndpy/- mice which may explain the delayed outgrowth of the SRVP. We also detected 
elevated mural cell coverage of the SRVP starting at P9, which is consistent with previously reported 
upregulation of Tie1, Pdgfβ and Pdgfrβ. Finally, we report for the first time endomucin positive 
supernumerary central filopodia of the SRVP in Ndpy/- retinas culminating at P9, the time point when the 
deep retinal vascular plexus (DRVP) normally would develop.  
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Results 
Vascular development in Norrin knockout mice 
The wildtype mouse retina is avascular at birth and outgrowth of the SRVP progresses from the center 
towards the periphery from P1 until P8. Because the outgrowth of the SRVP is incomplete and delayed 
in Ndpy/- mice (14), we hypothesized that there might be an imbalance between tip cell filopodia and/or 
adjacent stalk cell proliferation. We quantified the number of filopodia as well as the vascular density 
and number of branch points in the central plexus at the vascular front at P5 and P7 (Figure 1) 
(Supplementary Table 1). The number of filopodia was significantly increased and the vascular density 
(Figure 1 a, c, e, g, i, k) and the number of branch points (Figure 1 a, c, e, g, j, l) were significantly 
decreased at P5 and P7 in Ndpy/- mice. Moreover, filopodial protrusions in Ndpy/- mice are straighter and 
expand with a narrower angle than filopodia of wildtype littermates (Figure 1o) (Supplementary Table 
2). In contrast to the increased number of filopodia, the vascular front in general appears to be less 
ramified with a reduced amount of long tip cell protrusions (Figure 1 b, f).  
Comparison of vascular development in different mouse models 
Available morphometric data from three Norrin-Wnt signaling knockout mice (Fzd4 -/-, Lrp5 -/- and 
Tspan12 -/-), three Notch signaling knockout mice (Dll4 +/-, Jag1iΔEC, Nrarp-/-), Ang2LZ/LZ and Pax6 
dependent hypoxia inducible factor 1 α (HIF1α ΔPax6) knockout mice were compared (Table 1). The 
morphometric comparison of Jag1iΔEC with Ndpy/- mice was of special interest since Jag1 has been shown 
to be a canonical Wnt target gene in hair follicle cells comprising two LEF/TCF binding sites within its 
promoter region (26,27). We compared our morphometric data from Norrin KO mice with published 
morphometric data from Jag1iΔEC mice and recognized delayed and incomplete outgrowth of the SRVP, 
together with a reduced vascular density and a decreased number of branch points in Jag1iΔEC and Ndpy/- 
mice. In contrast to Ndpy/- mice, the number of tip cell filopodia was reduced in Jag1iΔEC mice. Dll4 +/- 
mice have an increased number of filopodia, increased number of branchpoints and a denser vascular 
SRVP. Hence, the Ndpy/- phenotype of the SRVP displays as an intermingled picture, with a peripheral 
Jag1 loss of function but central Jag1 gain of function features. We asked the question whether or not 
Norrin is a negative regulator of Notch signaling. To answer this question, we examined the effect of 
Notch inhibition in Ndpy/- mice in order to see if this may rescue the abnormal vascular development. 
We quantified and compared morphometric parameters in Norrin knockout and wildtype mice after 
inhibition of Notch signaling by injection of the γ-secretase inhibitor DAPT (Figure 2). Administration of 
DAPT increased vascular density in wildtype and Ndpy/- mice (Figure 2a-e), while the number of filopodia 
only increased in wildtype but not in Ndpy/- retinas (Figure 2f-j) (Supplementary Table 3).  
Retinal endothelial cell proliferation in Norrin deficient mice 
To test the hypothesis if Norrin acts as a mitogen for cells in the SRVP, which would explain the reduced 
vascular density as well as the delayed and incomplete radial vascular outgrowth in Ndpy/- mice, we 
quantified central endothelial cell proliferation after systemic bromodeoxyuridine (BrdU) injection and 
found significantly reduced proliferation rates of isolectin B4 positive ECs from the SRVP in Ndpy/- mice 
at P6 (WT: ME±SD 101.71 ± 16.54 ; KO: ME±SD 52.17 ± 9.62; p-value: 1.8E-5) (Figure 3a, c). The only 
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exception from this observation is local hotspots of proliferation within bulky unorganized regions at the 
vascular front (Figure 3d). Additionally, we monitored the effect of Norrin on cell cycle progression in 
cell culture experiments by using an E2F transcription factor-mediated reporter assay (cell proliferation 
controlling transcription factor dependent luciferase reporter construct, reviewed in (28)). For this, we 
transiently transfected pE2F luciferase reporter constructs into HEK293T cells which extopically express 
the same amount of either human wildtype (p.=) or a pathogenic variant of Norrin containing the p.C95R 
mutation (Supplementary Figure 1), which has been associated with the classic picture of Norrie disease 
(29). HEK293T cells do not endogenously express Norrin, but were positive in RT-PCR for transcripts 
from FZD4, LRP5 and TSPAN12 (Supplementary Figure 1). Similarly to our BrdU data in Ndpy/- mice, we 
found almost six-fold increased cell cycle progression in cells that stably express human wildtype Norrin 
compared to cells that express the mutant Norrin isoform (Figure 3f, Supplementary Table 4).  
Vascular remodeling in Norrin deficient mice 
Despite the reduced vascular outgrowth of the superficial layer we occasionally noticed bulky vascular 
areas at the front of Ndpy/- mice, comprising three dimensional accumulations of endothelial cells 
(Figure 4d). To monitor vascular remodeling across the plexus, retinal whole-mounts were double 
stained for isolectin B4 (IB4) and collagen IV (ColIV). Collagen IV positive tubes lacking IB4 staining 
represent empty basement membrane sleeves at positions where blood vessels have regressed (30,31). 
We noticed that vascular remodeling was elevated in Ndpy/- mice at peripheral bulky vascular areas of 
the SRVP, but not in central areas (Figure 4c, white dots). Furthermore, we noticed vessel-crossing in 
Ndpy/- retinas. Vessels that morphologically resemble veins (venous character, VC) cross and grow below 
vessels that resemble arteries (arterial character, AC) between P7 and P21 (A/V crossing) (Figure 5, 
Supplementary Figure 3). ACs in Norrin knockout mice also interconnect less to the central plexus 
compared to wildtype and instead grow further into the periphery (Figure 6d). At P21, disorganized 
twisted and tangled blood vessels form above the superficial plexus resembling fibrosis (Supplementary 
Figure 3t, w). We hypothesized that A/V crossing could be caused by altered astrocyte-EC interaction 
and therefore co-stained astrocytes against PDGFRα and blood vessels with isolectin B4 (Supplementary 
Figure 2). We did not observe an altered astrocytic network in Ndpy/- retinas compared to wildtype and 
alignment between astrocytes and ECs was normal.  
Mice lacking the Nrp1 cytoplasmatic domain or VEGFNES-CRE mice also show A/V crossing in the SRVP 
(24,25). This suggests that loss of MAPK signaling might cause this phenotype. Therefore we made use of 
our stably wildtype or p.C95R Norrin expressing HEK293T cell lines (Supplementary Figure 1) to monitor 
MAPK activity. We found a 1.9 fold increase of MAPK signaling in cells that express wildtype Norrin 
compared to those that expressed the mutant, disease-associated variant (Figure 5i, Supplementary 
Table 5).  
Because of the above described, strong SRVP phenotype in Ndpy/- mice, it was crucial to examine if the 
VCs and ACs exhibit characteristic molecular features of the respective vessel types. Retinal flatmounts 
were stained either for endomucin or for smooth muscle actin at P7, P9, P12 and P21. In both, wildtype 
and Ndpy/- mice, endomucin stained veins and venous portions while staining of arteries and arterioles 
was less intense (Figure 7, Supplementary Figure 4) (32,33). Interestingly, the endomucin staining 
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revealed supernumerary thorn-like assembled central sprouts around veins and capillaries of Ndpy/- 
retinas (Figure 7d, e). In contrast, capillary sprouts were much less abundant and, if present, much 
shorter in wildtype mice. Staining for the arterial and mural cell (MC) marker α-smooth muscle actin 
(SMA) in wildtype mice specifically labeled arteries at P7, P9 and P12 as well as arteries and large veins 
at P21. In Ndpy/- retinas, arteries, veins and capillaries were covered with SMA positive cells at P9, P12 
and P21. (Figure 7, Supplementary Figure 5). Thus, mural cell recruitment to the SRVP is abnormally 
increased in Ndpy/- retinas. 
Discussion 
Deficiency of Norrin is known to cause Norrie disease, a severe X-linked recessive human disease 
characterized by congenital blindness, progressive hearing loss and, in some patients, mental 
retardation. We made use of a mouse model which mimics the human disease in eye and ear and 
applied morphometric analyses, Notch-inhibition by DAPT administration, as well as cell proliferation 
assays to characterize the angiogenic processes in the retina. We provide evidence that Norrin is a 
mitogenic stimulus for cells in the SRVP. Consistently, wildtype Norrin promotes E2F transcription factor 
mediated cell cycle progression in a cell culture assay. Further, we identified endomucin as a marker for 
central filopodia, which were aligned in a thorn-like fashion at P9 in Ndpy/- mice. Finally, we found 
aberrant vascular SMA positive mural cell coverage of veins and capillaries from the SRVP in Ndpy/- mice 
which indicates abnormally increased mural cell recruitment of the SRVP from Norrin KO mice. 
 Norrin and Notch signaling are not directly linked 
We examined features of the SRVP in Ndpy/- mice by quantifying and comparing morphometric 
parameters (Figures 1&3, Supplementary Tables 1, 2 & 3) with published data from different mouse 
models with retinal vascular phenotypes (Table 1). We did not quantify later stages than P7 since the 
outgrowth of the superficial plexus in wildtype mice ends soon after this stage of development.  
We noticed that the outgrowth of the SRVP is delayed in all mouse models (Table 1), but incomplete 
vascular outgrowth was only observed in mutants with disrupted canonical Wnt signaling (Ndpy/-, Fzd4 -/- 
and Lrp5 -/-). Both, the deep and intermediate retinal vascular plexuses (DRVP, IRVP) are absent in mice 
with deficient Wnt signaling components (Ndpy/-, Fzd4 -/-, Lrp5 -/- and Tspan12 -/-) and in Ang2LZ/LZ mice, 
but not in Notch signaling deficient mice (Dll4+/- or Jag1iΔEC). The intermediate plexus is absent in 
HIF1αΔPax6 mice while the deep plexus is present (Table 1). We hypothesized that the canonical Wnt 
target gene Jag1 might link Norrin-Wnt and Notch signaling during development of the SRVP, since 
knocking out Ndp or Jag1 leads to aberrant SRVP development. However, we found significant 
differences in morphometric parameters between Ndpy/- and Jag1iΔEC retinas, which is in conflict with 
this hypothesis. The number of filopodia was increased in Ndpy/- and reduced Jag1iΔEC mice. Jag1iΔEC 
retinas also do not display defects in deep vascular development (22) which is a characteristic feature in 
Ndpy/- retinas. All these phenotypic differences suggest that there is no direct link between Norrin-Wnt 
and Notch signaling via Jag1. 
Inhibiting Notch signaling, through systemic DAPT administration led to an increased vascular density in 
Ndpy/- mice but it did not reduce the supernumerary filopodia. Furthermore, vascular density increased 
similarly in wildtype and Ndpy/- retinas after DAPT treatment, excluding a synergistic effect (Figure 3e). 
Accordingly, interaction effects were rejected by univariate analysis of variance (data not shown). 
Although the peripheral vascular network at the front is denser in DAPT-treated Ndpy/- mice (Figure 3d), 
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it still seems disorganized, three dimensional, and not planar. This implies that Notch inhibition can 
induce a peripheral hyper angiogenic response in Ndpy/- mice but not re-establish normal vascular 
development. The diameter of the peripheral blood vessels increased, which might be due to 
involvement of Dll4-Notch-signaling in A/V differentiation, leading to a more pronounced venous 
phenotype after DAPT injection and to an increase of vessel diameter (Figure 3a-d). The number of 
filopodia significantly increased in wildtype mice, but was unaltered in Ndpy/- retinas upon DAPT 
administration (Figure 3 g, I, j). 
 
Vascular remodeling in Norrin deficient mice 
We also found enhanced vascular proliferation (Figure 3) but also enhanced vascular 
regression/remodeling (Figure 4) at the vascular bulky front in Ndpy/- mice after BrdU injection and by 
co-staining of ColIV and isolectin B4. We interpret the vessel regression of Ndpy/- retinas as secondary 
effect which ensures a planar vascular plexus at positions where bulky vascular fronts were present 
before moving towards the periphery. Disorganized vascular fronts are also present in Fzd4+/-, Lrp5 -/- 
and Tspan12-/- retinas (12,13,34). Further, we observed extensive crossing of arteries and veins (A/V) in 
Ndpy/- retinas and we excluded an altered astrocytic scaffold to be the reason for these observations 
(Supplementary Figure 2).  
 
Loss of Norrin signaling might alter MAPK signaling 
A/V crossing is a feature of all Norrin-Wnt signaling deficient mice and also of VEGF-ANES-CRE and 
Nrp1cytoΔ/Δ mice (12,13,16,24). Also, the lack of the cytoplasmatic domain of Nrp1 (Nrp1cytoΔ/Δ) or dosage 
dependent reduction of neuronal VEGF-A paracrine signaling (VEGF-ANES-CRE) lead to A/V crossing (24,25). 
The receptor pair consisting of VEGFR2 and Nrp1 triggers VEGF mediated downstream MAPK signaling. 
Thus, the existence of A/V crossing in Ndpy/- retinas and in retinas from VEGF-ANES-CRE and Nrp1
cytoΔ/Δ mice 
suggests that both pathways influence each other. Supporting this, Norrin stimulated cells have elevated 
MAPK signaling activity compared to cells stimulated with mutant Norrin (Figure 5i). Similarly, we 
previously reported MAPK signaling to be the major pathway influenced by Norrin signaling according to 
transcriptome analyses using microarray data from Ndpy/- retinas (18). Therefore it will be intriguing to 
investigate the putative link between Norrin-Wnt and VEGF/Nrp1/MAPK signaling.  
 
Norrin stimulates mitogenic activity in retinal endothelial cells 
Since loss of Norrin leads to delayed and incomplete outgrowth of the SRVP, we analyzed the mitogenic 
activity of Norrin in mouse retinas and in cell culture using systemic BrdU injection and reporter assays, 
respectively. The reduced proliferation of IB4 positive ECs from the SRVP in Ndpy/- retinas, as revealed 
after BrdU injection, indicates that Norrin might act as a mitogenic stimulus (Figure 3). Additionally, we 
monitored cell cycle progression by using the pE2F luciferase reporter construct. As expected, HEK293T 
cells, which endogenously express FZD4, LRP5 and TSPAN12 but not Norrin, and ectopically express 
human wildtype Norrin had an increased cell cycle progression compared to ectopically p.C95R mutant 
Norrin expressing cells (Figure 3f). Consistently, Ohlmann et al., 2010 observed, by using a BrdU ELISA, 
that Norrin efficiently stimulates proliferation of human retinal microvascular endothelial cells (HMECS) 
in vitro in a Wnt dependent manner. Our findings together with the BrdU ELISA suggest that Norrin 
might act as a mitogenic stimulus on microvascular/capillary endothelial cells of the SRVP (Figure 3c). 
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This also can explain the delayed outgrowth of the SRVP. A key to understand the complexity of the 
retinal vascular phenotype in Ndpy/- mice could be the differentiated view of events at the angiogenic 
front and within the central plexus. Transient peripheral phenomena like local hotspots of proliferation 
and remodeling, thickening of the vasculature and supernumerary filopodia could be interpreted as 
inability of vascular sprouts to escape the existing plexus. Hence, filopodia-projecting tip cells could be 
overrun by stalk cells, cluster, and form the observed bulky areas. The supposed explanation for the 
Ndpy/- superficial plexus phenotype is also supported by in silico models of vascular network formation. 
Travasso et al. recently found, utilizing a mathematical model of sprouting angiogenesis, that low tip cell 
motility leads to a sparsely ramified plexus and increased stalk cell proliferation (36). Due to the lack of 
long tip cell protrusions projecting into the avascular space ahead of the vascular front, also 
characteristic for Ndpy/- mice, stalk cells spend more angiogenic factors which decrease its 
concentrations and inhibits branching. The same study highlights that low overall EC proliferation also 
leads to reduced vessel ramification, corroborating our observations. 
 
Veins and capillaries of Ndpy/- retinas possess supernumerary central filopodia  
To investigate the properties of ACs and VCs, we stained retinal whole-mounts against endomucin and 
SMA.  
The surface of veins and capillaries in Ndpy/- retinas was laced with endomucin positive filopodia instead 
of being smooth and covered with none or very few filopodia as in control mice. The abundance of 
central filopodia peaks around P9, exactly when deep vascular sprouting in wildtype mice occurs. 
Interestingly, deep sprouting exclusively originates from venous vessels and capillaries but not from 
arteries. Therefore it seems that veins and capillaries of the SRVP from Ndpy/- retinas are able to create 
misaligned central filopodia. However, these filopodia might not be functional, since Ndpy/- mice lack 
deep sprouting. It is also unclear which molecular mechanisms lead to those central supernumerary 
filopodia since published data focuses exclusively on the regulation of tip cell filopodia.  
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Veins and capillaries of Ndpy/- retinas are excessively covered by mural cells 
Staining of retinal blood vessels for SMA revealed extensive MC coverage of veins and capillaries from 
P9 onwards. This coverage persists at least till P21. We previously reported upregulation of PDGFβ and 
PDGFRβ within the same timeframe (14). Interaction of all these genes regulates MC recruitment. Here, 
overexpression of PDGFβ and its receptor (PDGFRβ) could stimulate MC recruitment and the missing 
upregulation of Ang1 on MCs might prevent restriction of MC recruitment. Considering this as the likely 
mechanism of the excessive MC recruitment, we believe that this might be a response to vessel 
leakiness caused by upregulation of VEGF-A and PLVAP (13,14,18) due to hypoxia. Currently, it is unclear 
if this extensive MC recruitment goes along with a gain of arterial character in the affected veins and 
venules. If so, the gain in arterial or loss of venous character could explain the disability to form the 
DRVP out of the SRVP from Ndpy/- retinas, since deep sprouts emerge exclusively from venous vessels 
and capillaries of the SRVP (38). The fact that we still can morphologically distinguish ACs and VCs and 
that we detected supernumerary endomucin positive central filopodia on veins, venules and capillaries, 
but not on arteries, argues against a complete loss of the venous character. However, the formation of 
uncoordinated central endomucin positive sprouts at P9 and the excessive MC recruitment of venous 
vessels may indicate at least a partial loss of venous identity of the respective endothelial cells with the 
consequence that central tip cells might develop, but being unable to induce proper deep sprouting.  
 
The morphometric analysis together with results from the DAPT injections do not suggest a direct link 
between Norrin-Wnt and Notch signaling. Our results suggest that Norrin is a mitogenic stimulus for IB4 
positive ECs of the SRVP which explains its delayed outgrowth in Ndp y/- mice. The A/V crossing occurs 
unlikely due to a disturbed astrocyte-EC interaction and it is unclear if the altered basal membrane of 
the SRVP contributes to this effect. We also found excessive MC coverage of veins, venules and 
capillaries in Ndpy/- retinas which might indicate a partial loss of venous identity but also contribute to 
the appearance of the altered basal lamina and possibly to the appearance of the thorn-like 
supernumerary central filopodia. Postnatal stages after P7 in mice mimic developmental stages from 
patients when hypoxia increases and leads to pathologic alterations of various retinal angiogenic 
maturation processes. Those data are crucial for the investigation of related diseases, like familial 
exudative vitreoretinopathy or Coats’ disease, with a less severe phenotype than Norrie disease, which 
have a realistic chance for the development of treatment regimens. 
Material and Methods 
Animals 
Generation of the Ndpy/- mouse line has been described elsewhere (4). The research was performed in 
accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and was 
approved by the Veterinary Office of the State of Zurich (Switzerland). 
 
Immunohistochemical staining 
Retinas for whole-mount immunohistochemistry were fixed in 4% paraformaldehyde for two hours or 
overnight at 4°C. After fixation, retinas were blocked using 1-10% normal goat or rabbit serum 
(VectorLabs) in PBST and subsequently incubated overnight with biotinylated isolectin B4 (1:200; 
VectorLabs). The following primary antibodies were diluted in 1-5% serum in PBST and incubated over 
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night: αSMA-CY3 (1:500; Sigma), Collagen IV (AbD serotec, 1:200), PDGFRα (R&D Systems, 1:500) and 
Endomucin (R&D Systems, 1:100). For secondary detection, Alexa Fluor streptavidin conjugates 
(Molecular Probes, 1:100) or anti-goat/rabbit Alexa Fluor-coupled secondary antibodies (Invitrogen, 
1:500) were used. Retinas were washed five times with PBS, flat mounted and analyzed under bright-
light illumination with a microscope (Axioplan 2, AxioCam HRc; Carl Zeiss ) equipped with ApoTome (Carl 
Zeiss) or by confocal imaging using the CLSM Leica SP2 inverse microscope (Leica). The protocol from 
Pitulescu et al., 2010 was used to stain for proliferating endothelial cells (BrdU staining). 
 
Image Processing 
Image J 1.44p (NIH), Photoshop CS5 (Adobe) software were used for image processing. Overall image 
brightness was adjusted in a linear fashion on whole images if it was necessary to improve picture 
quality for prints. These adjustments did not influence interpretation and are in concert with 
suggestions for image processing in (39). Results shown were obtained by performing at least two 
different independent experiments including at least four mutant or control animals per stage. 
 
Morphometric analysis of retinal flatmounts 
Each morphometric parameter was determined by averaging over four non-overlapping images per 
retina (one retina used per animal) with a minimum of four animals per group. Vascular density was 
determined by measuring the endothelial coverage per 300x300 µm field at the vascular front. The 
number of branch points was determined by counting vessel branch points within 300x300 µm fields. 
The number of filopodia at the vascular front within 68x51 µm fields was counted and normalized to 100 
µm length of vasculature. BrdU positive endothelial nuclei were counted in 424x317 µm fields at the 
vascular front and normalized to endothelial coverage within the same field (21). 
 
In vivo Notch inhibition  
Notch signaling was inhibited by subcutaneous injection of 0.3 mg/g body weight N-[N-(3,5-
Difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butylester (DAPT, Merck) dissolved in 10% ethanol and 
90% peanut oil. DAPT solution was injected twice at P5 and P6. Retinas were collected at P7. Control 
litters were injected with vehicle only. Seven litters were DAPT injected. Quantification of vascular 
density and number of filopodia in DAPT-treated versus untreated KO and WT mice were performed as 
described above (23).  
 
Quantification of Norrin dependent proliferation and MAPK signaling in vitro 
Stably wildtype or mutant C95R Norrin expressing HEK293T cells were used in these assays. Equal 
expression levels of wildtype and mutant Norrin were determined by western blot analysis (data not 
shown). To examine the proliferation rate or MAPK signaling activity, 8*104 cells/well of a 24-well plate 
were seeded and incubated at 37°C/5% CO2 overnight. Cells were transiently co-transfected with pE2F 
or pSRF firefly luciferase reporter and pRenilla constructs (SABiosciences) using the calcium precipitation 
method (40,41). Luciferase activity was measured using DualGlo-LuciferaseReporterAssaySystem 
(Promega). Firefly luciferase activity was normalized to co-transfected Renilla luciferase. 
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Statistical analysis  
Statistical analysis was performed in SPSS 18.0 (IBM) using two-tailed unpaired Student’s t-test.  
Quantitative data from DAPT-injection experiments were processed with univariate analysis of variance 
with two independent variables. Avoiding bias due to unequal sample sizes, the estimated marginal 
means where calculated instead of arithmetically means. P-values below α=0.05 were considered as 
significant. 
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Figures and Tables 
 
 
Figure 1. Morphometric parameters in norrin knockout versus wiltype mice. Ndphy/- mice show 
decreased vascular density, a decreased number of branch points but supernumerary filopodia, which 
are aligned in a more narrow angle compared to wildtype mice at P5 and P7. (a, e, c, g) Representative 
central retinal whole-mounts from wildtype (WT) and Ndphy/- (KO) retinas stained with isolectin B4 (IB4). 
(b, d, f, h)  Representative peripheral retinal whole-mounts from WT and Ndphy/- retinas stained with 
IB4. Emerging filopodia are visible. Quantification of vascular density (i, k), number of branch points (j, l), 
number of filopodia (m, n) and angle of filopodia (o). Average and confidence intervals are shown. P-
values below α=0.05 were considered statistically significant. Scale bars = 100 µm. 
15 
 
 
Figure 2. Effects of Notch signaling inhibition in wildtype and norrin knockout mice. Pharmacological 
administration of DAPT increases vascular density at the vascular front in wildtype and Ndphy/- mice. The 
number of filopodia only increases in wildtype but not in Ndphy/- mice upon DAPT treatment. (a, b, c, d) 
Representative retinal whole-mounts stained with isolectin B4 (IB4) 48h after DAPT injection in P7 
wildtype (WT) and Ndphy/- (KO) animals. (e) Statistical analysis shows that peripheral vascular density 
increases in both genotypes upon DAPT treatment. (f, g, h, i) Representative retinal whole-mounts of 
isolectin B4 staining 48h after DAPT treatment of P7 wildtype (WT) and Ndphy/- (KO) animals. Filopodia 
at the vascular front are visible. (j) Statistical analysis shows that number of filopodia increases only 
after DAPT treatment in WT but not in Ndphy/- mice. P-values below α=0.05 were considered statistically 
significant. Scale bars = 100 µm. 
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Figure 3. Decreased proliferation rate of endothelial cells in norrin knockout mice and reduced cell cycle 
progression due to a mutation (p.C95R) in human norrin. Overall proliferation is reduced in Ndphy/- mice 
at P6. Representative retinal whole-mounts of wildtype (WT) (a, b) and Ndphy/- mice (KO) (c, d) were 
stained for blood vessels with isolectin B4 (IB4, red) and for proliferating cells after BrdU incorporation 
(green). (d) Local hotspots of proliferation within thickened areas of the vascular front are occasionally 
seen in Ndphy/- mice and were excluded from quantification of proliferation. (e) Quantification of 
proliferating vascular endothelial cells after BrdU-incorporation revealed a reduced proliferation rate (- 
38%) in Ndphy/- mice. (f) Expression of wildtype norrin (WT) leads to 5.6-fold increase of proliferation 
rate in HEK293T cells compared to cells expressing a mutant (p.C95R) human norrin. RT = reverse 
transcriptase; Average and confidence intervals are shown. P-values below α=0.05 were considered 
statistically significant. Scale bars = 100 µm. 
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Figure 4. Massive vessel regression at the bulky vascular front in Ndphy/- mice at P7. Isolectin B4 (IB4, 
green) and collagenIV (ColIV, red) co-stained retinal whole-mounts from wildtype (WT) (a, b) and Ndphy/- 
mice (KO) (c, d). ColIV+, IB4- stainings represent empty membrane sleeves, where blood vessels have 
regressed (white dots). Regression was increased at the bulky vascular front in Ndphy/- retinas (d). Scale 
bars = 100 µm. 
 
Figure 5. Blood vessel crossing in norrin knockout mice. Arteries and veins often cross each other in 
Ndphy/- retinas. Retinal wholemounts of wildtype (WT) (a-c) and Ndphy/- mice (KO) (d-h) were stained 
with isolectin B4 (IB4) to label blood vessels (green a-f, or grey g+h). We noticed abundant artery/vein 
crossings at the center (e, arrowheads) and periphery (f, arrowheads) of the superficial retinal vascular 
18 
 
plexus from Ndphy/- retinas. Note, that (e) represents the box indicated in (d). (g) and (h) are confocal 
images from the blood vessels marked in (e), focused on the upper artery (g), and on the lower vein (h). 
(i) Ectopic expression of wildtype norrin (WT) leads to 1.9-fold increase of MAPK signaling in HEK293T 
cells compared to cells expressing a mutant (p.C95R), disease-associated human norrin. The distance 
between both vessels is 3.58 µm. a = artery, ac = arterial character, v = vein, vc = venous character. Scale 
bars = 100 µm 
 
Figure 6. Large central filopodia in Ndphy/- mice at P9. Retinal whole-mounts from wildtype (WT) (a-c) 
and Ndphy/- mice (KO) (d-f) were co-stained with isolectin B4 (IB4, green) to label blood vessels and with 
endomucin (red) which preferentially stains veins, venous vessels and central filopodia. (b) represents 
box in (a), (e) represents box in (d). Endomucin staining revealed that vessels with a venous morphology 
(vc) but not with an arterial morphology (ac) are laced with supernumerary central filopodia. a = artery, 
v = vein. Scale bars = 100 µm. 
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Figure 7. Retinal veins and capillaries are abundantly covered by vascular smooth muscle cells (vSMCs) 
in Ndphy/- mice at P12. Retinal whole-mounts were co-stained with isolectin B4 (IB4) to label blood 
vessels (green) and against smooth muscle actin (SMA) to label arteries covered by vSMCs (red). Only 
arteries were covered by vSMCs in wildtype (WT) retinas. In contrast, arteries, veins and capillaries were 
covered by vSMCs in Ndphy/- retinas (KO). a = artery, ac = arterial character, v = vein, vc = venous 
character. Scale bars = 100 µm. 
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Table 1: Morphometric data among mutant mice with comparable retinal vascular phenotype 
 Ndpy/- Fzd4 -/- Lrp5 -/- Tspan12 -/- Dll4 +/- Jag1iΔEC Nrarp-/- Ang2LZ/LZ HIF1α ΔPAX6 
Pathway 
affected 
Canonical Wnt- 
signaling 
Canonical 
Wnt- signaling 
Canonical Wnt- 
signaling 
Canonical Wnt- 
signaling 
Notch-
signaling 
Notch-
signaling; 
tamoxifen 
induced EC 
specific 
deletion 
Notch, β-
catenin/Lef1-
dependent Wnt-
signaling 
Tie2-signaling; 
LZ = lacZ 
Hypoxia 
Vascular 
outgrowth of 
SRVP 
delayed and 
incomplete 
delayed and 
incomplete 
delayed 
and incomplete 
delayed 
and incomplete 
delayed delayed  
(-44%) 
delayed but 
complete 
periphery remains 
avascular 
not delayed nor 
reduced 
Vascular density 
of SRVP 
reduced 
(-34%, P7) 
not available not available reduced increased 
(+58%*) 
reduced  
(-32%, P6) 
reduced at P5 but 
not different in 
adult 
not available not available 
Number of 
branch points of 
SRVP 
reduced  
(-47%, P7) 
not available not available not available increased 
(+96%*) 
reduced  
(-65%, P6) 
reduced at P5 but 
not different in 
adult 
not available not available 
Number of 
filopodia of 
SRVP 
increased 
(+39%, P7) 
not available not available not avaiable increased 
(sprouts 
increased 
+63%*) 
reduced  
(-27%, P6) 
not different at 
P5 
not available not available 
A/V crossing in 
SRVP till P7 
present present present present absent absent present Not deducible 
due to picture 
quality 
absent 
deep retinal 
vascular plexus 
absent absent absent absent present present present absent present 
intermediate 
retinal vascular 
plexi 
absent absent absent absent present present present absent absent 
References Luhmann et 
al., 2005 (14), 
this work 
Xu et al., 2004 
(12) 
Xia et al., 2008 
and 2010 
(16,42,43) 
Junge et al., 2009 
(13) 
Lobov et al., 
2007 (21) 
Benedito et 
al., 2009 (22) 
Phng et al., 2009 
(35)  
Gale et al., 2002 
(44) 
Caprara et al., 
2011 (45) 
*) % estimated from graph 
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Supplementary Figures 
 
 
 
Supplementary Figure 1 HEK293T cells endogenously express Norrin receptors but no Norrin and 
the quantity of ectopic expression of wildtype and p.C95R Norrin in HEK293T cells is the same in 
both cell lines. (a) HEK293T cells used for this assay endogenously express FZD4, LRP5, TSPAN12 but 
no NDP. (b) Western blot analysis from protein extracts of HEK293T cells that express either 
wildtype (WT) or p.C95R (p.C95R) mutant Norrin or Mock (HEK293T). The arrow indicates the 
respective Norrin which appear slightly above 17 kDa.   
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Supplementary Figure 2 Alignment of endothelial cells and astrocytes. Astrocyte/endothelial cell 
alignment is not altered in Ndphy/- mice at P7. Blood vessels of wildtype (WT) (a-f) and Ndphy/- 
retinas (KO) (g-l) were stained with isolectin B4 (IB4) to label blood vessels (green) and against 
PDGFRα to label astrocytes (red). Astrocytes align around the covering blood vessels in WT and KO 
mice. The density of the retinal astrocytic network at the avascular front is similar in Ndphy/- and 
wildtype retinas (m,n). Scale bar = 100 μm. 
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Supplementary Figure 3 Vessel crossing in norrin knockout mice. Arteries and veins often cross each 
other in Ndphy/- retinas between P7 and P21. Retinal wholemounts of wildtype (WT) (a-l) and Ndphy/- 
mice (KO) (m-w) were stained with isolectin B4 (IB4) to label blood vessels (green). We noticed 
abundant artery/vein crossing at the center (q, s, t) and in the periphery (u, v, w) of the superficial 
retinal vascular plexus from Ndphy/- retinas. a = artery, ac = arterial character, v = vein, vc = venous 
character. Scale bars = 100 µm 
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Supplementary Figure 4 Ndphy/- mice display small central filopodia at P12 and P21. Retinal 
flatmounts from wildtype (WT) (a-h) and Ndphy/- mice (KO) (i-r) were co-stained with isolectin B4 
(IB4, green) to label blood vessels and with endomucin (red), which preferentially stained veins, 
venous vessels and central filopodia. (q) represents box in (l), (r) represents the box in (p). 
Endomucin staining revealed that vessels with venous character (vc) but no vessels with an arterial 
character (ac) are laced with small supernumerary central filopodia at P12 and P21 but not at P7. At 
P21, vessels grew above the superficial retinal vascular plexus resembling fibrosis. Fibrous vessels 
with vc but not ac were also laced with small filopodia (l, p, q, r). a = artery, v = vein. Scale bars = 100 
µm. 
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Supplementary Figure 5 Increased smooth muscle cell coverage of retinal veins and capillaries in 
norrin knockout mice. Retinal veins and capillaries are abundantly covered by vascular smooth 
muscle cells (vSMCs) in Ndphy/- mice at P9 and P21. Retinal flatmounts were co-stained with isolectin 
B4 (IB4) to label blood vessels (green) and against smooth muscle actin (SMA) to label arteries 
covered by vSMCs (red). Arteries were covered by vSMCs in wildtype (WT) retinas at P7 and P9 and 
arteries and veins at P21. In contrast, arteries, veins and capillaries were covered by vSMCs in 
Ndphy/- retinas (KO) between P9 and P21. At P21, some areas of the superficial retinal vascular 
plexus (SRVP) are abundantly overgrown with blood vessels resembling fibrosis (m, r). Overgrowth 
with blood vessels is prevented in other areas of the SRVP (l, q). These areas display drum stick like 
elongations that are entirely covered by vSMCs (arrowhead). a = artery, ac = arterial character, v = 
vein, vc = venous character. Scale bars = 100 µm. 
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Supplementary Table 1  Morphometric data from wildtype and NDPhy/- retinas 
 wildtype retinas NDPhy/- retinas 
P5 
Number of filopodia 23 ± 2 (n=5) 32 ± 5 (n=6; p-value = 0.001) 
Vascular density 42 ± 5 (n=5) 30 ± 4 (n=5; p-value = 0.002) 
Number of 
branchpoints 
30 ± 1 (n=5) 14 ± 3 (n=5; p-value <0.0001) 
P7 
Number of filopodia 21 ± 3 (n=4) 29 ± 2 (n=7, p-value <0.0001) 
Vascular density 48 ± 4 (n=5) 32 ± 3 (n=7; p-value = 0.0006) 
Number of 
branchpoints 
89 ± 7 (n=5) 47 ± 8 (n=7; p-value <0.0001) 
average ± standard deviation are reported; n= number of retinas; 
Supplementary Table 2 Filopodia angle 
 wildtype retinas  NDPhy/- retinas 
Filopodia angle in ° 62.6 ± 29.0 (n=109) 51.0 ± 24.7 (n=109; p-value=0.002) 
average ± standard deviation are reported; n= number of filopodia;  
Supplementary Table 3 Quantification of morphometric parameters from wildtype and NDPhy/- mice 
after DAPT injection 
M
ea
n 
fil
op
od
ia
 
pe
r 
10
0 
μm
  WT +DAPT WT -DAPT KO +DAPT KO -DAPT 
WT +DAPT 36 ± 7 (n=6) p-value = 0.012 p-value =0.022  
WT -DAPT  21 ± 3 (n=4)  p-value = 0.025 
KO +DAPT   27 ± 5 (n=6) p-value = 0.279 (N.S.) 
KO -DAPT    30 ± 4 (n=4) 
M
ea
n 
va
sc
ul
ar
 
de
ns
ity
 
 WT +DAPT WT -DAPT KO +DAPT KO -DAPT 
WT +DAPT 72 ± 6 (n=6) p-value = 0.00005 p-value = 0.149 (N.S.)  
WT -DAPT  46 ± 5 (n=4)  p-value = 0.323 (N.S.) 
KO +DAPT   66 ± 8 (n=6) p-value = 0.00067 
KO -DAPT    42 ± 5 (n=4) 
M
ea
n 
va
sc
ul
ar
 
le
ng
th
 
 WT +DAPT WT -DAPT KO +DAPT KO -DAPT 
WT +DAPT 87 ± 3 (n=6) p-value = 0.075 
(N.S.) 
p-value = 0.00002  
WT -DAPT  83 ± 1 (n=4)  p-value = 0.00003 
KO +DAPT   70 ± 5 (n=6) p-value = 0.022 
KO -DAPT    62 ± 2 (n=4) 
average ± standard deviation are reported; n= number of retinas;  
Supplementary Table 4 Cell cycle progression 
 WT norrin  p.C95R norrin 
Cell cycle progression 5.60 ± 0.61 (n=3) 0.99 ± 0.07 (n=3; p-value=0.00021) 
average ± standard deviation are reported; n= number of technical replicas;  
Supplementary Table 5 MAPK activity 
 WT norrin  p.C95R norrin 
MAPK activity 1.00 ± 0.040 (n=3) 0.53 ± 0.052 (n=3; p-value=0.00023) 
average ± standard deviation are reported; n= number of technical replicas;  
